Krystal Biotech, Inc. (KRYS) Shareholders’ equity 2021–2025
Krystal Biotech, Inc. (KRYS) shareholders’ equity at each fiscal year-end, per SEC filings.
$1.2BFY2025 · since FY2021: $593.6M → $1.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.2B | +28.9% |
| FY2024 | $946.4M | +21.5% |
| FY2023 | $778.6M | +49.1% |
| FY2022 | $522.2M | -12.0% |
| FY2021 | $593.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice